...
首页> 外文期刊>Bangladesh Journal of Veterinary Medicine >Production of formalin killed fowl typhoid vaccine using local isolates of Salmonella Gallinarum in Bangladesh
【24h】

Production of formalin killed fowl typhoid vaccine using local isolates of Salmonella Gallinarum in Bangladesh

机译:使用孟加拉国沙门氏菌沙门氏菌的局部分离株生产福尔马林杀死的禽伤寒疫苗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Mozaffor 11.6568 Normal 0 false false false MicrosoftInternetExplorer4 st1:*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable{mso-style-name:"Table Normal";mso-tstyle-rowband-size:0;mso-tstyle-colband-size:0;mso-style-noshow:yes;mso-style-parent:"";mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-para-margin:0cm;mso-para-margin-bottom:.0001pt;mso-pagination:widow-orphan;font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:#0400;mso-fareast-language:#0400;mso-bidi-language:#0400;} A locally isolated Salmonella Gallinarum (SG) was used for fowl typhoid vaccine production. 2 x 10 7 colony forming unit (CFU) of SG was used for the vaccine production. The fowl typhoid vaccine was produced with the local isolates of SG (LRI 49) strain. Efficacy study of the vaccine was performed primarily in laboratory trial in 6 weeks and then in 8 weeks old commercial layers in the field. Chickens were boasted after 4 wks of vaccination. Rapid serum plate agglutination (SPA) test and ELISA were carried out for the detection of antibody response against SG vaccinated and non-vaccinated birds. Positive results of the rapid plate agglutination and the ELISA were 81% and 77% in laboratory trial, and 76.4% and 73.8% in field trial, respectively. The chickens of vaccinated and non-vaccinated groups were challenged with the infective dose (2 x 2 x 10 7 CFU) of freshly prepared live SG bacteria and lesions were not detected in vaccinated birds at necropsy.?? The vaccine was proved safe and effective in terms of preventing of fowl typhoid in chickens in Bangladesh. ?? Key words: Fowl typhoid vaccine, potency, ELISA, plate agglutination test, Salmonella Gallinarum ???? DOI = 10.3329/bjvm.v5i1.1306 Bangl. J. Vet. Med. (2007). 5 (1 & 2): 33-38
机译:Mozaffor 11.6568正常0虚假虚假MicrosoftInternetExplorer4 st1 :* {behavior:url(#ieooui)} / *样式定义* / table.MsoNormalTable {mso-style-name:“ Table Normal”; mso-tstyle-rowband-size: 0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:“”; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:“ Times New Roman”; mso-ansi语言:#0400; mso-fareast语言:#0400; mso-bidi-language:#0400;}使用本地分离的沙门氏菌沙门氏菌(SG)生产家禽伤寒疫苗。 SG使用2 x 10 7集落形成单位(CFU)进行疫苗生产。禽伤寒疫苗是用SG(LRI 49)菌株的局部分离株生产的。疫苗的功效研究主要在6周的实验室试验中进行,然后在野外的8周龄商业层进行。接种4周后将鸡烧掉。进行了快速血清平板凝集(SPA)测试和ELISA,以检测针对SG接种和未接种SG禽的抗体应答。快速平板凝集和ELISA的阳性结果在实验室试验中分别为81%和77%,在现场试验中分别为76.4%和73.8%。接种疫苗组和未接种疫苗组的鸡都受到感染剂量(2 x 2 x 10 7 CFU)新鲜制备的活SG细菌的攻击,尸检时未在接种疫苗的禽类中发现病灶。在预防孟加拉国鸡的禽伤寒方面,该疫苗被证明是安全有效的。 ??关键词:禽伤寒疫苗,效价,ELISA,平板凝集试验,鸡沙门氏菌DOI = 10.3329 / bjvm.v5i1.1306 Bangl。 J.兽医中(2007)。 5(1&2):33-38

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号